• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21959 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Votubia) for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis - first line or post surgery
2014     NIHR Horizon Scanning Centre (NIHR HSC) Minicare H-2000 remote monitoring system for patients undergoing chemotherapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Generex Oral-lyn (buccal insulin) for diabetes mellitus
2008     NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for schizophrenia in children and adolescents
2011     NIHR Horizon Scanning Centre (NIHR HSC) Girentuximab (Rencarex) for renal cell carcinoma
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ciclosporin (CicloMulsion) for reperfusion injury prevention prior to percutaneous coronary intervention for ST-segment elevation acute myocardial infarction
2007     NIHR Horizon Scanning Centre (NIHR HSC) Pregabalin (Lyrica) for fibromyalgia
2008     NIHR Horizon Scanning Centre (NIHR HSC) Aripiprazole (Abilify) for children and adolescents with bipolar disorder
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for early stage ErbB2 (HER2) over-expressing breast cancer - adjuvant treatment
2014     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human alpha-mannosidase (Lamazym) for alpha mannosidosis
2007     NIHR Horizon Scanning Centre (NIHR HSC) Milnacipran for fibromyalgia
2008     NIHR Horizon Scanning Centre (NIHR HSC) Canakinumab for cryopyrin associated periodic syndrome
2011     NIHR Horizon Scanning Centre (NIHR HSC) Lapatinib (Tyverb) for squamous cell carcinoma of the head and neck - adjuvant and maintenance therapy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Metreleptin for generalised and partial lipodystrophy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Prucalopride (Resolor) for chronic constipation
2011     NIHR Horizon Scanning Centre (NIHR HSC) Nitazoxanide for influenza - first line
2014     NIHR Horizon Scanning Centre (NIHR HSC) myVisionTrack® for monitoring degenerative eye disease
2007     NIHR Horizon Scanning Centre (NIHR HSC) Magnetic Source Imaging (MSI) for the characterisation and localisation of epileptic abnormalities and brain tumours
2008     NIHR Horizon Scanning Centre (NIHR HSC) AVE0010 (ZP10) for type 2 diabetes mellitus
2011     NIHR Horizon Scanning Centre (NIHR HSC) Pazopanib (Votrient) for ovarian, fallopian or peritoneal cancer
2014     NIHR Horizon Scanning Centre (NIHR HSC) Tabalumab for systemic lupus erythematosus
2007     NIHR Horizon Scanning Centre (NIHR HSC) SpeechEasy altered auditory feedback device for stammer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Insulin glulisine (Apidra) for type 1 diabetes mellitus in adolescents and children
2011     NIHR Horizon Scanning Centre (NIHR HSC) Perampanel for epilepsy - adjunctive
2014     NIHR Horizon Scanning Centre (NIHR HSC) SafePlace for the peripheral insertion of central venous catheters in infants
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2008     NIHR Horizon Scanning Centre (NIHR HSC) Exenatide once-weekly for type 2 diabetes mellitus - second or third line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Phentermine/topiramate (Qnexa) for weight loss and maintenance of weight loss
2014     NIHR Horizon Scanning Centre (NIHR HSC) Interferon beta-1a (Traumakine) for acute respiratory distress syndrome – first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) CNTO-1275 (Ustekinumab) for moderate to severe psoriasis
2008     NIHR Horizon Scanning Centre (NIHR HSC) Alteplase (Activase) for the early (up to 4.5 hours) treatment of acute ischaemic stroke
2011     NIHR Horizon Scanning Centre (NIHR HSC) Rivaroxaban (Xarelto) for acute coronary syndrome
2014     NIHR Horizon Scanning Centre (NIHR HSC) Mepolizumab for severe refractory eosinophilic asthma – first line
2006     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for breast cancer - metastatic, first line (in combination with non-taxanes): horizon scanning technology briefing
2008     NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe (Ezetrol) for hypercholesterolaemia in adolescents
2011     NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for early stage parkinson's disease - adjuvant therapy
2014     NIHR Horizon Scanning Centre (NIHR HSC) Brodalumab for moderate to severe plaque psoriasis
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sunitinib (Sutent) for advanced and/or metastatic breast cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Picoplatin for small cell lung cancer - second line
2011     NIHR Horizon Scanning Centre (NIHR HSC) Safinamide for mid-to-late stage parkinson's disease - adjuvant therapy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Decitabine for acute myeloid leukaemia
2011     NIHR Horizon Scanning Centre (NIHR HSC) Sipuleucel-T (Provenge) for metastatic castration resistant prostate cancer - first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with bevacizumab for advanced or metastatic non-small cell lung cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for prevention of bone metastases in prostate cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Strontium ranelate (Protelos) for osteoarthritis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vepoloxamer for vaso-occlusive crises in sickle cell disease – first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Sorafenib (Nexavar) for advanced non-small cell lung cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) BIBW 2992 (Tovok) for advanced or metastatic non-small cell lung cancer after failure of at least one reversible EGFR inhibitor
2011     NIHR Horizon Scanning Centre (NIHR HSC) Zonisamide (Zonegran) for newly diagnosed partial seizures in epilepsy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for refractory follicular lymphoma – third line in combination with bendamustine
2007     NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima) for advanced or metastatic non-small cell lung cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) in combination with docetaxel for metastatic breast cancer - first line
2011     NIHR Horizon Scanning Centre (NIHR HSC) LAS 41005 (Actikeral) for actinic keratosis - first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Medidur for non-infectious posterior uveitis – second line
2007     NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for recurrent and/or unresectable squamous cell carcinoma of the head and neck
2008     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) for non small cell lung cancer advanced or metastatic-maintenance monotherapy
2011     NIHR Horizon Scanning Centre (NIHR HSC) Romidepsin (Istodax) for peripheral T-cell lymphoma, relapsed and/or refractory - second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Epoetin alfa (Eprex) for anaemia in adults with low or intermediate-1 risk myelodysplastic syndromes
2007     NIHR Horizon Scanning Centre (NIHR HSC) INGN 201 (contusugene ladenovec; Advexin) for Li-Fraumeni syndrome associated cancers
2008     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG162) for the prevention of therapy-induced bone loss in non-metastatic breast and prostate cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Tivozanib for renal cell cancer, locally advanced or metastatic - first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Naldemedine for opioid-induced constipation in adults
2007     NIHR Horizon Scanning Centre (NIHR HSC) Arsenic trioxide (Trisenox) for acute promyelocytic leukaemia - first line therapy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Denosumab (AMG 162) for bone metastases from solid tumours and multiple myeloma
2011     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab-DM1 (Herceptin-DM1) for breast cancer, locally advanced or metastatic, HER2 positive - second or third line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Dacomitinib for advanced or metastatic non-small cell lung cancer – second or third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pegvaliase for the treatment of hyperphenylalaninaemia in adults with phenylketonuria – first line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Plerixafor (Mozobil) for stem-cell mobilisation in multiple myeloma
2008     NIHR Horizon Scanning Centre (NIHR HSC) Amrubicin for small cell lung cancer - relapsed and/or refractory, extensive disease
2011     NIHR Horizon Scanning Centre (NIHR HSC) Trastuzumab SC (Herceptin SC) for breast cancer, early or metastatic, HER2 positive - monotherapy or combination therapy, including neo-adjuvant and adjuvant use
2012     NIHR Horizon Scanning Centre (NIHR HSC) Dovitinib for metastatic renal cell carcinoma
2016     NIHR Horizon Scanning Centre (NIHR HSC) KRN23 for X-linked hypophosphataemia in children aged 5-12 years – first line
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2011     NIHR Horizon Scanning Centre (NIHR HSC) Mipomersen for familial hypercholesterolemia - third or fourth line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Enobosarm (Ostarine) for cachexia in patients with advanced non-small cell lung cancer – first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Eribulin mesilate (Halaven) for advanced non-small cell lung cancer – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin (Jardiance) for preventing cardiovascular death in patients with type 2 diabetes mellitus and high cardiovascular risk
2007     NIHR Horizon Scanning Centre (NIHR HSC) Rituximab (Mabthera) for non-Hodgkin’s lymphoma – first line maintenance therapy
2008     NIHR Horizon Scanning Centre (NIHR HSC) Rolofylline for acute heart failure
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bromocriptine, quick release (Syncroset) for type 2 diabetes mellitus
2012     NIHR Horizon Scanning Centre (NIHR HSC) Enzastaurin for diffuse large B-cell lymphoma – following complete remission
2013     NIHR Horizon Scanning Centre (NIHR HSC) Olaparib for relapsed platinum-sensitive ovarian cancer
2016     NIHR Horizon Scanning Centre (NIHR HSC) Empagliflozin (Jardiance) for type 1 diabetes – adjunctive therapy
2007     NIHR Horizon Scanning Centre (NIHR HSC) Aflibercept (VEGF Trap) for advanced chemo-refractory epithelial ovarian cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Lorcaserin hydrochloride (APD-356) for obesity or overweight people with at least one co-morbidity
2011     NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin for systemic anaplastic large cell lymphoma relapsed and/or refractory - first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (Afinitor) for advanced, unresectable or metastatic neuroendocrine tumours
2013     NIHR Horizon Scanning Centre (NIHR HSC) Plitidepsin (Aplidin) in combination with dexamethasone for multiple myeloma – third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Venetoclax with rituximab for relapsed or refractory chronic lymphocytic leukaemia – second and subsequent line
2007     NIHR Horizon Scanning Centre (NIHR HSC) Trabectedin (Yondelis) for relapsed ovarian cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for heart failure with preserved systolic function
2011     NIHR Horizon Scanning Centre (NIHR HSC) Brentuximab vedotin for Hodgkin's lymphoma, relapsing or remitting - first line
2012     NIHR Horizon Scanning Centre (NIHR HSC) Nanoliposomal irinotecan for metastatic pancreatic cancer in patients who have progressed on prior gemcitabine-based therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Darapladib for cardiovascular risk reduction in patients with coronary heart disease – add on therapy
2016     NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep in combination with paclitaxel for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
2007     NIHR Horizon Scanning Centre (NIHR HSC) Vandetanib (Zactima, -6474, AZD-6474, ZD6474) for medullary thyroid cancer – locally advanced or metastatic
2008     NIHR Horizon Scanning Centre (NIHR HSC) Irbesartan (Aprovel) for prevention of cardiovascular complications in patients with persistent atrial fibrillation
2011     NIHR Horizon Scanning Centre (NIHR HSC) Zibotentan in combination with docetaxel for prostate cancer, metastatic, castration resistant - in combination with docetaxel
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ofatumumab (Arzerra) for maintenance treatment in relapsed chronic lymphocytic leukaemia (CLL) patients responding to induction therapy
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ezetimibe and simvastatin (Inegy) for reduction of cardiovascular risk in coronary heart disease